These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 37149607)

  • 21. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-targeting aptamers act as intracellular delivery vehicles.
    Gopinath SC; Lakshmipriya T; Chen Y; Arshad MK; Kerishnan JP; Ruslinda AR; Al-Douri Y; Voon CH; Hashim U
    Appl Microbiol Biotechnol; 2016 Aug; 100(16):6955-69. PubMed ID: 27350620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical Modifications for a Next Generation of Nucleic Acid Aptamers.
    Chan KY; Kinghorn AB; Hollenstein M; Tanner JA
    Chembiochem; 2022 Aug; 23(15):e202200006. PubMed ID: 35416400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review.
    Pang X; Cui C; Wan S; Jiang Y; Zhang L; Xia L; Li L; Li X; Tan W
    Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29425173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An exploration of aptamer internalization mechanisms and their applications in drug delivery.
    Wan LY; Yuan WF; Ai WB; Ai YW; Wang JJ; Chu LY; Zhang YQ; Wu JF
    Expert Opin Drug Deliv; 2019 Mar; 16(3):207-218. PubMed ID: 30691313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
    Macedo B; Cordeiro Y
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA and RNA aptamers: from tools for basic research towards therapeutic applications.
    Ulrich H; Trujillo CA; Nery AA; Alves JM; Majumder P; Resende RR; Martins AH
    Comb Chem High Throughput Screen; 2006 Sep; 9(8):619-32. PubMed ID: 17017882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Advances in Aptamers for Cancer Diagnosis and Therapy.
    Hori SI; Herrera A; Rossi JJ; Zhou J
    Cancers (Basel); 2018 Jan; 10(1):. PubMed ID: 29301363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy.
    Wei Z; Zhou Y; Wang R; Wang J; Chen Z
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy.
    Fu Z; Xiang J
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancing Aptamers as Molecular Probes for Cancer Theranostic Applications-The Role of Molecular Dynamics Simulation.
    Jeevanandam J; Tan KX; Danquah MK; Guo H; Turgeson A
    Biotechnol J; 2020 Mar; 15(3):e1900368. PubMed ID: 31840436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy.
    Zhu H; Li J; Zhang XB; Ye M; Tan W
    ChemMedChem; 2015 Jan; 10(1):39-45. PubMed ID: 25277749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing Aptamers by Cell-Based SELEX.
    Catuogno S; Esposito CL; de Franciscis V
    Methods Mol Biol; 2016; 1380():33-46. PubMed ID: 26552814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-SELEX: in vitro selection of synthetic small specific ligands.
    Dickinson H; Lukasser M; Mayer G; Hüttenhofer A
    Methods Mol Biol; 2015; 1296():213-24. PubMed ID: 25791604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid-Type SELEX for the Selection of Artificial Nucleic Acid Aptamers Exhibiting Cell Internalization Activity.
    Uemachi H; Kasahara Y; Tanaka K; Okuda T; Yoneda Y; Obika S
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.